Review: in type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia
- PMID: 25599366
- DOI: 10.7326/ACPJC-2015-162-2-006
Review: in type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia
Comment on
-
Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis.Lancet. 2014 Dec 20;384(9961):2228-34. doi: 10.1016/S0140-6736(14)61335-0. Epub 2014 Sep 11. Lancet. 2014. PMID: 25220191
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical